Top Markets
#1 Black Phoenix Black Phoenix +823.46%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.03%
#3 Beam Beam +24.43%
#4 Tutorial Tutorial +24.41%
#5 Not in Employment, Education, or Training Not in Employment, Education, or Training +21.87%
#6 Bless Bless +19.73%
#7 SAFEcoin SAFEcoin +18.55%
#8 Magma Finance Magma Finance +17.14%
#9 THORChain THORChain +16.18%
#10 EfficientFrontier EfficientFrontier +15.73%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
BGI Genomics Co., Ltd. BGI Genomics Co., Ltd.

BGI Genomics Co., Ltd.

300676
Classifica tra le azioni #5740
BGI Genomics Co., Ltd. operates as an international supplier of genetic testing... BGI Genomics Co., Ltd. operates as an international supplier of genetic testing solutions and sequencing services. The company caters to a broad clientele, encompassing medical and research facilities, as well as other public and private organizations, both within China and across the globe. Its comprehensive service portfolio includes DNA, RNA, and tailored sequencing options. Additionally, it offers a suite of specialized genetic tests such as non-invasive prenatal testing (NIPT), reproductive health screening, and newborn genetic screening, alongside clinical exome sequencing. BGI Genomics also develops clinical and research-focused solutions for the field of oncology. During the COVID-19 pandemic, the firm provided crucial laboratory solutions for the detection and diagnosis of suspected cases, including SARS-CoV-2 IgM and IgG antibody detection kits, and real-time fluorescent RT-PCR kits. Their expertise spans numerous research domains, including but not limited to agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug development. Established in 1999, the company initially operated under the name Shenzhen BGI Medicine Co., Ltd. before officially changing to BGI Genomics Co., Ltd. in 2015. Its corporate headquarters are located in Shenzhen, China.
Prezzo delle azioni
$5.91
Capitalizzazione di mercato
$2.47B
Variazione (1 giorno)
0.10%
Variazione (1 anno)
-22.57%
Paese
CN
Scambia BGI Genomics Co., Ltd. (300676)

Categoria

Healthcare
Ricavi di BGI Genomics Co., Ltd. (300676)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di BGI Genomics Co., Ltd., i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per BGI Genomics Co., Ltd. da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $46.34B -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $25.11B -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 $2.71B -
US
Agilent Technologies, Inc. Agilent Technologies, Inc.
Agilent Technologies, Inc.
A.US
 $7.23B -
US